|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0009 - 0.0012|
|52 Week Range||0.0001 - 0.0014|
|Beta (3Y Monthly)||-4.88|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Contract Signed with Financial Consultant to Lead Capital Raise For Expansion Corporate Progress FRUITLAND, ID / ACCESSWIRE / October 2, 2019 / XTRA BITCOIN INC (OTC PINK:TCEL) $TCEL $xtrabitcoin: XTRA's ...
XTRA's Board has approved adding a new team member to assist in raising expansion capital. Among the accomplishments to date are agreements to reduce interest rate on all outstanding debt and the elimination of all convertible debt to protect against dilution of shareholder value. XTRA hopes to finalize consultant's contract next week.
FRUITLAND, ID / ACCESSWIRE / August 22, 2019 / XTRA Bitcoin Inc. (OTC PINK:TCEL) XTRA’s management is assembling the documentation requested by FINRA in response to our corporate action notification regarding merger and name change. Complying with the FINRA requests is the required first step towards bringing our filings current. After FINRA, bringing filings current on OTC to remove the STOP sign is a prerequisite condition to obtaining funding.
FRUITLAND, ID / ACCESSWIRE / August 6, 2019 / Progress report update for $TCEL and $XTRA (OTC PINK:TCEL). Situation: OTC Markets will not accept filings to bring current (remove STOP sign) until Name Change ...
Name Change, Merger Complete, Cancel Reverse Split, Officer Change, Twitter CHEYENNE, WY / ACCESSWIRE / July 15, 2019 / Great news shareholders of $TCEL and $XTRA. MERGER COMPLETE! THERAPY CELLS, INC. ...
CHEYENNE, WY / ACCESSWIRE / June 18, 2019 / THERAPY CELLS, INC. (OTC Pink: TCEL) Therapy Cells, Inc. has been unsuccessful in raising the required capital to pursue the FDA approval of the growing of Tendon ...